By: Jet Villa, InterAksyon.com August 6, 2013 4:34 PM InterAksyon.com The online news portal of TV5 MANILA, Philippines - Amid a flurry of reports about unregulated procedures that have led to serious injury or even deaths, the Professional Regulation Commission (PRC) is now requiring foreign doctors wishing to practice stem cell therapy in the Philippines to obtain a special temporary permit (STP). In a position statement, the Professional Regulatory Board of Medicine (PRBOM) said foreign doctors must submit proof of education, training and clinical experience and actual practice in the field of stem cell therapy, plus a current license to practice authenticated by the Philippine Embassy/Consulate in the country of origin when they apply for the special permits. The board warned: Any foreign physician who practices the professionwithout a STP will be criminally liable for illegal practice of medicine.And, it added, those who have aided and abetted the foreign physicianspractice of the profession are also criminally liable. The position paper was signed by PRBOM chairman Dr. Edgardo Fernando and members doctors Miguel Noche Jr., Florentino Doble, Restituto de Ocampo, Jose Cueto Jr., and Mildred Pareja. Controversy hounds new group The position statement on stem cell therapy was issued amid a … Continue reading →

Annual General Meeting approves agenda with a clear majority Executive Board and Supervisory Board have been discharged Outlook for the 2013 fiscal year confirmed Berlin, Germany, August 7, 2013 - MagForce AG (Frankfurt, Entry Standard, XETRA: MF6), a leading medical device company in the field of nanomedicine focused on oncology, held its annual general meeting yesterday, August 6, 2013, in Berlin. The annual general meeting approved all of the items on the agenda with a clear majority and granted discharge to the Executive and Supervisory Boards for the 2012 fiscal year. The Executive Board members Prof. Dr. Hoda Tawfik and Christian von Volkmann provided a status update regarding current operational developments, an overview of the 2012 fiscal year and the outlook for the current year. The Executive and Supervisory Boards were pleased with the outcome of the resolutions. The Executive Board`s presentation is available from the company`s website at http://www.magforce.de/presse-investoren/hauptversammlung (German only). About MagForce AG MagForce AG is a leading medical device company in the field of nanomedicine in oncology. The Company`s proprietary, NanoTherm therapy, enables the targeted treatment of solid tumors through the intratumoral generation of heat via activation of superparamagnetic nanoparticles. NanoTherm, NanoPlan, and NanoActivator(TM) are components of … Continue reading →

Hera Nalbandian - High School Stem Cell Research Intern - Summer 2013, Video Project 2 Visit our Through Their Lens page for photos and more videos from students and grantees: http://www.cirm.ca.gov/instagram-CIRMStemCellLab-feed Hera Nalbandia... By: California Institute for Regenerative Medicine … Continue reading →

Dying 2 year old to be couples best man Christine Swidorsky and Sean Stevenson may be counting the hours until their wedding this Saturday, but the day will be bittersweet. The couple's 2-year-old ... By: L.N TİDİNGS … Continue reading →

Capitol Pain Austin - Dr. Schocket - Stem Cell Treatment for Low Back Pain Patient discussing her stem cell treatment for low back pain performed by Dr. Schocket at Capitol Pain Institute, your Austin Pain Management Specialists. By: Matt Schocket … Continue reading →

Aug. 7, 2013 Researchers at the University of Southampton, in collaboration with colleagues at the University of Cambridge, have developed a technique to help treat fatal diseases more effectively. Dr Sumeet Mahajan and his group at the Institute for Life Sciences at Southampton are using gold nanoprobes to identify different types of cells, so that they can use the right ones in stem cell therapies. Stem cell therapy is in its infancy, but has the potential to change the way we treat cancer and other life-threatening diseases, by replacing damaged or diseased cells with healthy ones. One of the key limitations of stem cell therapy is identifying the right cells to use for different therapies. This fundamental problem with the treatment is being tackled by this new research. Dr Mahajan, Senior Chemistry Lecturer in Life Science Interface, says: "Stem cells could hold the key to tackling many diseases. They develop into all the various kinds of cells needed in the body -- blood, nerves and organs -- but it is almost impossible to tell them apart during their initial development without complex techniques, even with the most advanced microscopes. Up to now, scientists have used intrusive fluorescent markers to tag … Continue reading →

Researchers studying diseases with an unknown cause may have a new method to try, as scientists reverse engineered a new bacterium responsible for a syndrome discovered fewer than two years ago. The quest began in 2011, after doctors reported a syndrome they called cord colitis in a small group of patients treated with umbilical cord stem cells for blood cancer and other hematologic diseases. Researchers at Dana-Faber Cancer Institute in Boston hypothesized that the new ailment, which responded to antibiotics, stemmed from a previously unknown infectious agent. Bacteria are typically identified after investigators obtain a living sample and grow it in laboratory dishes. In the case of cord colitis, all the researchers had was preserved biopsy specimens from colons of treated patients that werent alive and couldnt grow. After sequencing the DNA from the specimens and eliminating those identified as human, they began assembling pieces of the genetic jigsaw puzzle that was left. If these patients had an infection, there should be human cells and bacterial cells, said Ami Bhatt, the lead researcher and a clinical fellow in hematology and oncology at Dana-Faber. What I expected to find was some weird variety of E. coli or a similar bacteria found … Continue reading →